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Abstract
This paper explores conformal prediction in the learning under privileged information
(LUPI) paradigm. We use the SVM+ realization of LUPI in an inductive conformal predic-
tor, and apply it to the MNIST benchmark dataset and three datasets in drug discovery.
The results show that using privileged information produces valid models and improves
efficiency compared to standard SVM, however the improvement varies between the tested
datasets and is not substantial in the drug discovery applications. More importantly, using
SVM+ in a conformal prediction framework enables valid prediction intervals at specified
significance levels.
Keywords: Learning Under Privileged Information, LUPI, SVM, SVM+, conformal
prediction, drug discovery
1. Introduction
The growing availability of data offers great opportunities but also many challenges to
develop models which can be used to make predictions about future observations. The
classical machine learning paradigm is: given a set of training examples in the form of iid
pairs
(x1, y1), ..., (xl, yl), xi ∈ X, yi ∈ {−1,+1} (1)
seek a function that approximates the unknown decision rule in the best possible way
and provides the smallest probability of incorrect classifications. Training examples are
represented as features xi and the same feature space is required for predicting future
observations. However this approach does not make use of other useful data that is only
available at training time; such data is referred to as Privileged Information (PI) (Vapnik
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and Vashist, 2009). Hence much data that could improve models is set aside and not
included in the training process.
In the Learning Using Privileged Information (LUPI) paradigm, training examples in-
stead come in the form of iid triplets
(x1, x
∗
1, y1), ..., (xl, x
∗
l , yl), xi ∈ X, x∗i ∈ X∗, yi ∈ {−1,+1} (2)
where x∗ denotes PI. The objective is the same as in classical machine learning, with the
extension that privileged information is available in the training stage. One implementation
of LUPI is SVM+, and Vapnik and Vashist (2009) showed that this approach and imple-
mentation can accelerate the learning process, and outperform classical machine learning
in a set of applications.
Conformal prediction (Vovk et al., 2005) is a method that provides a layer on top of
an existing machine learning method and uses available data to determine valid prediction
regions for new examples. In contrast to standard machine learning that delivers point
estimates, conformal prediction yields a prediction region that contains the true value with
probability equal to or higher than a predefined level of confidence. Such a prediction region
can be obtained under the assumption that the observed data is exchangeable.
In this work we explore conformal prediction in the LUPI paradigm with the aim to
improve predictive performance and obtain valid prediction regions. We study the effects of
the SVM+ realization of LUPI in an inductive conformal predictor on a benchmark dataset
and provide examples in drug discovery problems where machine learning has become a
core part of the early discovery process (Norinder et al., 2014; Bendtsen et al., 2017; Zhang
et al., 2017).
2. Data and Methods
2.1 Support Vector Machines (SVM)
Support vector machines (Vapnik and Vapnik, 1998), are one of the most successful meth-
ods for classification in machine learning. One of the key concepts of SVM is the use of
separating hyperplanes to define decision boundaries, and the optimal decision hyperplane
is a plane in a multidimensional space that separates between data points of different classes
and that also maximizes the margin, separating the two classes. SVM uses the kernel trick
to generate a high dimensional nonlinear representation of the input data examples where
it performs the separation with a continuous separation hyperplane, such that the distances
of misclassified data examples from the hyperplane are minimized. In this study, we use
a classification SVM for training our classification models with a Radial Basis Function
(RBF) kernel
K(xi, xj) = exp(−γ‖xi − xj‖2),
where γ controls the width of the kernel function, and xi and xj are the vectors of the
ith and the jth training samples, respectively. The kernel parameters γ and the SVM cost
parameter C are tuned using two-dimensional cross-validated grid search.
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2.2 SVM+
Realizations of LUPI (Vapnik and Vashist, 2009) are mostly based on SVM and referred
to as SVM+. In SVM+, the privileged information (PI) is used to estimate the slack
variables, which are defined as the distance between the support vectors and the decision
boundary. The PI provides a means for regularizing the SVM optimization problem and
assists in its generalization. This can be also viewed as augmenting the standard SVM with
a second kernel that defines a similarity measure between any two data points in a privileged
information space. We use RBF for both kernels, where the first kernel parameters are tuned
using SVM on X (standard features) and the second kernel parameter is tuned using using
SVM on X∗ (PI).
2.3 Conformal prediction
Traditional machine learning algorithms for classification problems simply predicts the class
labels without any confidence. Conformal predictors expand on this as they output predic-
tion regions for a specific confidence level provided by the user. The confidence value is an
indication of how likely each prediction is of being correct, for example, a confidence of 95%
implies that the percentage prediction error will be 5% on average. Conformal predictors
are built on top of traditional machine learning algorithms, referred to as underlying algo-
rithms, and they can be broadly categorized into transductive and inductive approaches;
we refer to Papadopoulos (2008) for more details. We here consider the inductive approach
called Inductive Conformal Prediction (ICP), which is more computationally efficient as
compared with the transductive approach. In particular, we use Mondrian ICP with SVM
or SVM+ as the underlying algorithms, and the SVM or SVM+ distance to the decision
boundary to define the non-conformity measures (NCM). Mondrian conformal prediction
has the advantage that we achieve validity for the individual classes. To evaluate the per-
formance of conformal predictors, we consider the observed fuzziness, as defined in Vovk
et al. (2005).
2.4 Data
As a reference dataset we used the MNIST dataset (LeCun et al., 1998), which has been
used previously with the SVM+ algorithm (Vapnik and Vashist, 2009). The MNIST dataset
contains grayscale images of handwritten digits 0-9 as vectors of 28 x 28 pixel images, and
was downloaded from http://yann.lecun.com/exdb/mnist/. We used a 4000 example
subset of MNIST dataset comprising digits 5 and 8. The original 28× 28 pixel images were
used as PI, where images resized to 8 × 8 pixel resolution were used as standard dataset.
We also used three datasets in drug discovery (Hansen, MMP, and AHR), where chemical
structures are represented as numerical features, and the response variable is measured in
a biological assay. The Hansen dataset (Hansen et al., 2009) was constructed to enable the
prediction of mutagenicity for the chemical structure of e.g. a drug candidate, based on
measurements from the Ames Mutagenicity test (Zeiger and Mortelmans, 2001). The MMP
dataset is based on measurements for small molecule disruptors of the Mitochondrial Mem-
brane Potential, and is commonly used to assess the effect of chemicals on mitochondrial
function (Sakamuru et al., 2016). The AHR dataset is based on measurements for interac-
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tion with the aryl hydrocarbon receptor (AHR), related to chemical toxicity and interaction
with drugs and other compounds (Bradshaw and Bell, 2009). AHR and MMP were down-
loaded from PubChem (AHR PubChem AID: 743122, MMP PubChem AID: 720637) as
part of the Tox21 project that has previously been used for modeling (Huang et al., 2016).
The Hansen dataset was downloaded from http://doc.ml.tu-berlin.de/toxbenchmark/.
The chemical structures in the datasets AHR, MMP and Hansen were represented using ten
Physical-Chemical descriptors (Chi1n, Chi2n, Chi3n, Chi4n, Chi0v, C hi1v, Chi2v, Chi3v,
Chi4v and MolLogP), and Morgan fingerprints calculated using RDKit (www.rdkit.org).
The Physical-Chemical descriptors contains less features and can be hypothesized to pro-
duce less accurate models than Morgan fingerprints. All the datasets are binary class
problems with class labels (-1, 1). The details of the datasets are given in Table 1.
Table 1: Description of the datasets and feature sets used in this work
Dataset Features # Observations # Features
MNIST X: 8× 8 pixel images 4000 64
X*: 28× 28 pixel images 4000 784
AHR X: Phys-chem descriptors 6299 10
X*: Morgan fingerprints 6299 55725
Hansen X: Phys-chem descriptors 6509 10
X*: Morgan fingerprints 6509 48325
MMP X: Phys-chem descriptors 5647 10
X*: Morgan fingerprints 5647 49764
2.5 Study design
We denote X = (x1, ..., xl)
T , as a matrix of standard features, X∗ = (x∗1, ..., x∗l )
T , as a
matrix of PI, and y = (y1, ..., yl), as a vector of class labels. We chose three statistical
models: SVM on X, SVM on X∗ and SVM+ on X with X∗ as PI. These three models were
applied on all four datasets to compare their predictive accuracy and efficiency (observed
fuzziness). First, the dataset was partitioned using stratified-split into two parts: training
(80%) and external test (20%) set, and the training and the test sets were then kept fixed.
Then the training set was randomly divided into proper-training (70%) and a calibration
set (30%). For tuning the parameters for each model and for each dataset, we used five-fold
cross validation technique on the corresponding proper-training set, and we selected the
parameters based on the highest prediction accuracy. More importantly, the tuning was
performed in three steps:
1. Tuning of the first RBF kernel parameter, γ1, and the SVM parameter, C1, for the
model SVM on X: We used two dimensional grid search with 5-fold CV on the X-
proper-training set.
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2. Tuning of the second RBF kernel parameter, γ2, and the SVM parameter, C2, for
the model SVM on X∗: We used two dimensional grid search with 5-fold CV on the
X∗-proper-training set.
3. Tuning of SVM+ parameters, C and γ: We used two dimensional grid search with
5-fold CV on the X-proper-training and X∗-proper-training with selected kernel pa-
rameters, γ1 and γ2, in the previous steps.
Table 2: Hyper parameter ranges for various methods
Method C γ
SVM on X [.1, 1000] [1e-7, 1]
SVM on X∗ [.1, 1000] [1e-7, 1]
SVM+ on X (with X∗ as PI) [.01, 100] [1e-4, .1]
The ranges explored for each parameter and for each method are given in Table 2.
The proper-training set with corresponding selected parameters was then used to build the
model. The non-conformity scores were computed on the corresponding calibration set. We
used the SVM/SVM+ decision function to define the non-conformity measure (NCM)
αi = yif(xi),
where f is the SVM/SVM+ decision function. Then for each observation in the external
test set, we computed (Mondrian) conformal prediction p-values for each class. The above
procedure was repeated 10 times, and the average predictive performance, and the average
observed fuzziness was reported. The above-mentioned steps are outlined in Algorithm 1.
2.6 Computational Details
The computations were performed on resources provided by SNIC through Uppsala Multi-
disciplinary Center for Advanced Computational Science (UPPMAX) under Project SNIC
2017-7-273. We used existing Python implementation of LibSVM in scikit-learn toolkit for
training and prediction SVM models. We implemented SVM+ on Python using python-
cvxopt: Python package for convex optimization. Conformal prediction using SVM as
an underlying machine learning algorithm was implemented in Python using scikit-learn
toolkit.
3. Results and Discussion
In this study, we have used prediction accuracy and observed fuzziness as measures of
performance. The prediction accuracies of the three statistical models are given in Table
3 and in Figure 1, and we observe that the methodology using SVM on X* outperforms
the other models in terms of prediction accuracy for all datasets, but we note that SVM+
outperforms SVM on X for most of the datasets.
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Input: (X, X∗, y), N: number of repetitions
Output: average prediction accuracy, average validity, average observed fuzziness
Step 1: Partition the dataset (X, X∗, y) into 80% for training, and 20% for testing
using stratified split.
Step 2: Partition the training set, (X, X∗, y)-training, into 70% proper-training and
30% calibration.
Step 3: Use cross-validation for tuning C1 and γ1, using SVM on X-proper-training,
and select the one that gives the highest average prediction accuracy.
Step 4: Use cross-validation for tuning C2 and γ2, using SVM on X
∗-proper-training,
and select the one that gives the highest average prediction accuracy.
Step 5: Use cross-validation for tuning C and γ, using SVM+ on X-proper-training
with X∗-proper-training as PI, and the kernel parameters γ1 and γ2 as selected in
Step 3 and Step 4 respectively.
Step 6:
repeat
Step 6.1: Randomly partition the (X, X∗, y)-training set into 70% for proper-
training, and 30% for calibration.
Step 6.2: Train the three models using their corresponding proper-training set.
Step 6.3: Compute NCM using the corresponding calibration set for each model.
Then for each model compute the following on their corresponding test set:
- prediction accuracy
- deviation from exact validity
- observed fuzziness
until N iterations;
Return average prediction accuracy, average validity and average observed fuzziness
of each model.
Algorithm 1: Algorithm for study design: ICP with SVM and SVM+
For comparison of the three Mondrian inductive conformal predictors, their measure
of efficiency and validity are given in Table 4 and in Figure 2. The smaller the efficiency
(observed fuzziness) is, the better the model performs. Also here we see that SVM on X*
performs best in terms of efficiency, and that SVM on X* outperforms SVM on X for all
datasets, but that the level of improved efficiency with SVM+ varies between the datasets.
One implication of using SVM+ is the need for tuning additional SVM hyper-parameters
associated with PI, which increases the computational complexity substantially.
4. Conclusions
We here introduced conformal prediction using LUPI/SVM+ as underlying method. We
investigated the validity and efficiency of inductive conformal predictors with SVM+ on the
MNIST benchmark dataset, and also applied it to three datasets relevant to drug discovery.
Our results show that the ICP with SVM+ is more efficient than ICP with SVM on X,
in terms of observed fuzziness. We also showed that the prediction accuracy of SVM+ on
6
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Table 3: Comparison of prediction accuracy
Dataset Statistical Model prediction accuracy
MNIST SVM on X 0.939125
SVM on X∗ 0.987375
SVM+ on X with X∗ as PI 0.942875
AHR SVM on X 0.888889
SVM on X∗ 0.917857
SVM+ on X with X∗ as PI 0.888889
Hansen SVM on X 0.669124
SVM on X∗ 0.809370
SVM+ on X with X∗ as PI 0.676651
MMP SVM on X 0.847522
SVM on X∗ 0.896726
SVM+ on X with X∗ as PI 0.849292
Figure 1: Comparision of prediction accuracy on four selected datasets using SVM on X
(pink), SVM on X*(yellow) and SVM+ (blue).
X with X* as privileged information is better than standard SVM on X for all datasets,
however in some cases the improvements on observed fuzziness and prediction accuracy are
only marginal.
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Table 4: Comparision of validity and efficiency
Dataset Learning Algorithm Validity observed fuzziness
MNIST SVM on X 0.189254 0.015103
SVM on X∗ 0.182684 0.000839
SVM+ on X with X∗ as PI 0.176197 0.013733
AHR SVM on X 0.168761 0.272146
SVM on X∗ 0.107204 0.092754
SVM+ on X with X∗ as PI 0.100159 0.226047
Hansen SVM on X 0.121286 0.285467
SVM on X∗ 0.128802 0.127245
SVM+ on X with X∗ as PI 0.130737 0.283943
MMP SVM on X 0.164847 0.260612
SVM on X∗ 0.140734 0.098628
SVM+ on X with X∗ as PI 0.151952 0.248843
Figure 2: Comparision of observed fuzziness on four selected datasets using SVM on X
(pink), SVM on X*(yellow) and SVM+ (blue).
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